Pediatric adjuvant formulation offers protection against RSV in newborns
Respiratory syncytial virus (RSV) is the main world reason for loss of life in youngsters below age 5 and lacks an efficient vaccine. In a examine from the Precision Vaccines Program at Boston Youngsters's Hospital, a brand…